They copped it for how they delivered the 6 month data, so it just looks like they're giving themselves a bit of time to best package this new information for release to the general market.
Just another landmark reached. This data completes the 008 set, so they can now a) further inform interested partners on duration of treatment effects, and b) begin arrangements to discuss potential for DMOAD clinical trial pathway with the FDA.
Ann: Trading Halt, page-9
-
- There are more pages in this discussion • 63 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $76.95M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 23.5¢ | 22.0¢ | $66.95K | 294.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 90092 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 25858 | 1 |
View Market Depth
| Last trade - 16.10pm 14/08/2024 (20 minute delay) ? |
| PAR (ASX) Chart |